References

Alonso, A. and M.A. Hernan, 2008. Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurol., 71: 129-135.
Direct Link  |  

Debouverie, M., S. Pittion-Vouyovitch, S. Louis and F. Guillemin, 2008. Natural history of multiple sclerosis in a population-based cohort. Europ. J. Neurol., 15: 916-921.
CrossRef  |  

Henriksson, F., S. Fredrikson, Т. Masterman and B. Jonsson, 2001. Costs, quality of life and disease severity in MS. Europ. J. Neurol., 8: 27-36.

Kuroiwa, Y., H. Shibasaki, M. Ikeda, 1983. Prevalence of multiple sclerosis and its North-South gradient in Japan. Neuroepidemiology, 2: 62-69.
CrossRef  |  

Kurtzke, J.F., 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev., 6: 382-427.
Direct Link  |  

Marrie, R.A., 2004. Environmental risk factors in multiple sclerosis aetioligy. Lancet Neurol., 3: 709-718.
CrossRef  |  

Poser, C.M., 1994. The epidemiology of multiple sclerosis: A general overview. Ann. Neurol., 36: 231-234.
CrossRef  |  

Rogan, E., 2014. Activities of the European multiple sclerosis platform. Eur. Neurol., 72: 43-46.
CrossRef  |  

Rosati, G., 2001. The prevalence of multiple sclerosis in the world: An update. Neurol. Sci., 22: 117-139.
Direct Link  |  

Shmidt, T.Y. and N.N. Yahno, 2010. Multiple Scleroses. MED Press-Inform, Russia, ISBN: 5-98322-632-1, Pages: 272.

Simpson, S., Jr, BV. Taylor and I. Van Der Mei, 2015. The role of epidemiology in MS research: Past successes, current challenges and future potential. Mult. Scler. J., 10.1177/1352458515574896

Stolyarov, I.D. and A.N. Boyko, 2008. Multiple Sclerosis: Diagnosis, treatment, specialists. ELBI-SPB., St. Petersburg, Russia, Pages: 320.